A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies

Lisa N. Wasilewski, Ramy El-Diwany, Supriya Munshaw, Anna E. Snider, Jillian K. Brady, William O. Osburn, Stuart C. Ray, Justin R. Bailey

Research output: Research - peer-reviewArticle

Abstract

Hepatitis C virus (HCV) infection is a global health problem, with millions of chronically infected individuals at risk for cirrhosis and hepatocellular carcinoma. HCV vaccine development is vital in the effort toward disease control and eradication, an undertaking aided by an increased understanding of the mechanisms of resistance to broadly neutralizing antibodies (bNAbs). In this study, we identified HCV codons that vary deep in a phylogenetic tree of HCV sequences and showed that a polymorphism at one of these positions renders Bole1a, a computationally derived, ancestral genotype 1a HCV strain, resistant to neutralization by both polyclonal-HCV-infected plasma and multiple broadly neutralizing monoclonal antibodies with unique binding epitopes. This bNAb resistance mutation reduces replicative fitness, which may explain the persistence of both neutralizationsensitive and neutralization-resistant variants in circulating viral strains. This work identifies an important determinant of bNAb resistance in an ancestral, representative HCV genome, which may inform HCV vaccine development.

LanguageEnglish (US)
Pages3773-3782
Number of pages10
JournalJournal of Virology
Volume90
Issue number7
DOIs
StatePublished - 2016

Fingerprint

Hepatitis C virus
neutralizing antibodies
neutralization
monoclonal antibodies
genetic polymorphism
Neutralizing Antibodies
Hepacivirus
Monoclonal Antibodies
Serum
vaccine development
Vaccines
risk groups
hepatoma
resistance mechanisms
codons
epitopes
disease control
mutation
genome
genotype

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies. / Wasilewski, Lisa N.; El-Diwany, Ramy; Munshaw, Supriya; Snider, Anna E.; Brady, Jillian K.; Osburn, William O.; Ray, Stuart C.; Bailey, Justin R.

In: Journal of Virology, Vol. 90, No. 7, 2016, p. 3773-3782.

Research output: Research - peer-reviewArticle

@article{cf2fc6c28d1c4515b81e4ce81a37c588,
title = "A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies",
abstract = "Hepatitis C virus (HCV) infection is a global health problem, with millions of chronically infected individuals at risk for cirrhosis and hepatocellular carcinoma. HCV vaccine development is vital in the effort toward disease control and eradication, an undertaking aided by an increased understanding of the mechanisms of resistance to broadly neutralizing antibodies (bNAbs). In this study, we identified HCV codons that vary deep in a phylogenetic tree of HCV sequences and showed that a polymorphism at one of these positions renders Bole1a, a computationally derived, ancestral genotype 1a HCV strain, resistant to neutralization by both polyclonal-HCV-infected plasma and multiple broadly neutralizing monoclonal antibodies with unique binding epitopes. This bNAb resistance mutation reduces replicative fitness, which may explain the persistence of both neutralizationsensitive and neutralization-resistant variants in circulating viral strains. This work identifies an important determinant of bNAb resistance in an ancestral, representative HCV genome, which may inform HCV vaccine development.",
author = "Wasilewski, {Lisa N.} and Ramy El-Diwany and Supriya Munshaw and Snider, {Anna E.} and Brady, {Jillian K.} and Osburn, {William O.} and Ray, {Stuart C.} and Bailey, {Justin R.}",
year = "2016",
doi = "10.1128/JVI.02837-15",
volume = "90",
pages = "3773--3782",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies

AU - Wasilewski,Lisa N.

AU - El-Diwany,Ramy

AU - Munshaw,Supriya

AU - Snider,Anna E.

AU - Brady,Jillian K.

AU - Osburn,William O.

AU - Ray,Stuart C.

AU - Bailey,Justin R.

PY - 2016

Y1 - 2016

N2 - Hepatitis C virus (HCV) infection is a global health problem, with millions of chronically infected individuals at risk for cirrhosis and hepatocellular carcinoma. HCV vaccine development is vital in the effort toward disease control and eradication, an undertaking aided by an increased understanding of the mechanisms of resistance to broadly neutralizing antibodies (bNAbs). In this study, we identified HCV codons that vary deep in a phylogenetic tree of HCV sequences and showed that a polymorphism at one of these positions renders Bole1a, a computationally derived, ancestral genotype 1a HCV strain, resistant to neutralization by both polyclonal-HCV-infected plasma and multiple broadly neutralizing monoclonal antibodies with unique binding epitopes. This bNAb resistance mutation reduces replicative fitness, which may explain the persistence of both neutralizationsensitive and neutralization-resistant variants in circulating viral strains. This work identifies an important determinant of bNAb resistance in an ancestral, representative HCV genome, which may inform HCV vaccine development.

AB - Hepatitis C virus (HCV) infection is a global health problem, with millions of chronically infected individuals at risk for cirrhosis and hepatocellular carcinoma. HCV vaccine development is vital in the effort toward disease control and eradication, an undertaking aided by an increased understanding of the mechanisms of resistance to broadly neutralizing antibodies (bNAbs). In this study, we identified HCV codons that vary deep in a phylogenetic tree of HCV sequences and showed that a polymorphism at one of these positions renders Bole1a, a computationally derived, ancestral genotype 1a HCV strain, resistant to neutralization by both polyclonal-HCV-infected plasma and multiple broadly neutralizing monoclonal antibodies with unique binding epitopes. This bNAb resistance mutation reduces replicative fitness, which may explain the persistence of both neutralizationsensitive and neutralization-resistant variants in circulating viral strains. This work identifies an important determinant of bNAb resistance in an ancestral, representative HCV genome, which may inform HCV vaccine development.

UR - http://www.scopus.com/inward/record.url?scp=84960947640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960947640&partnerID=8YFLogxK

U2 - 10.1128/JVI.02837-15

DO - 10.1128/JVI.02837-15

M3 - Article

VL - 90

SP - 3773

EP - 3782

JO - Journal of Virology

T2 - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 7

ER -